Viagra 100 - Adelphi Research

Sildenafil citrate, or Viagra, changed the landscape of ED treatment with its ability to inhibit PDE5 selectively. This process helps maintain higher cGMP levels, essential for smooth muscle relaxation and increased blood flow. After comprehensive trials involving over 4,500 participants, Viagra was approved in 1998 and quickly became the primary treatment for ED due to its efficacy and tolerability. As a long-lasting solution with an adaptable dose range, Sildenafil remains a leading option, offering clinically proven results for individuals seeking effective and safe ED management.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Viagra 100 by Adelphi Research, consult with your doctor or healthcare professional.